Your browser doesn't support javascript.
loading
Photochemical generation of radicals from alkyl electrophiles using a nucleophilic organic catalyst.
Schweitzer-Chaput, Bertrand; Horwitz, Matthew A; de Pedro Beato, Eduardo; Melchiorre, Paolo.
Afiliación
  • Schweitzer-Chaput B; ICIQ, Institute of Chemical Research of Catalonia-the Barcelona Institute of Science and Technology, Tarragona, Spain.
  • Horwitz MA; ICIQ, Institute of Chemical Research of Catalonia-the Barcelona Institute of Science and Technology, Tarragona, Spain.
  • de Pedro Beato E; ICIQ, Institute of Chemical Research of Catalonia-the Barcelona Institute of Science and Technology, Tarragona, Spain.
  • Melchiorre P; ICIQ, Institute of Chemical Research of Catalonia-the Barcelona Institute of Science and Technology, Tarragona, Spain. pmelchiorre@iciq.es.
Nat Chem ; 11(2): 129-135, 2019 02.
Article en En | MEDLINE | ID: mdl-30510217
ABSTRACT
Chemists extensively use free radical reactivity for applications in organic synthesis, materials science, and life science. Traditionally, generating radicals requires strategies that exploit the bond dissociation energy or the redox properties of the precursors. Here, we disclose a photochemical catalytic approach that harnesses different physical properties of the substrate to form carbon radicals. We use a nucleophilic dithiocarbamate anion catalyst, adorned with a well-tailored chromophoric unit, to activate alkyl electrophiles via an SN2 pathway. The resulting photon-absorbing intermediate affords radicals upon homolytic cleavage induced by visible light. This catalytic SN2-based strategy, which exploits a fundamental mechanistic process of ionic chemistry, grants access to open-shell intermediates from a variety of substrates that would be incompatible with or inert to classical radical-generating strategies. We also describe how the method's mild reaction conditions and high functional group tolerance could be advantageous for developing C-C bond-forming reactions, for streamlining the preparation of a marketed drug, for the late-stage elaboration of biorelevant compounds and for enantioselective radical catalysis.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Chem Asunto de la revista: QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nat Chem Asunto de la revista: QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: España
...